CAHC's internal projections show the draft Senate bill can reverse the expected premium increases under the House legislation and extend coverage to four to five million more consumers.
FDA Commissioner outlines plans to speed approval of new drugs that mirrors recommendations released by CAHC earlier this year.
Event to be hold one day after rate filing deadline for 2018 plans, will discuss the health of the current marketplace and reforms needed to protect access to coverage.
We need less bickering and more answers. That starts with bringing all factions of the healthcare industry together to identify a consensus-based approach to reducing drug costs, which is exactly what we have done through our Prescriptions for Affordability initiative.
Coalition urges lawmakers to "come together to unwind this failed law responsibly and ensure that consumers have a glide path – not an obstacle course– to a more affordable healthcare system."
Says score highlights imperfections of House-passed bill and need for stronger legislation in the Senate.